Drawing for DBITE

USPTO serial 99885409

DBITE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SEBREE, NATHAN ALEXANDER
Law office
TMO LAW OFFICE 139

What this means

Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.

Status 638: Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months.

Need help with DBITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Elizabeth K. Rucki

Elizabeth K. Rucki Amgen Inc.One Amgen Center DriveThousand Oaks, CA 91320-1799United States

Goods and services

ClassDescriptionStatusFirst use
005Medicaments, namely, polypeptides, for use in the treatment of tumorous diseases, cancer, allergies, autoimmunity, inflammation, osteoporosis, graft versus host diseases, transplant rejection, cardiovascular diseases, metabolic diseases, neurological diseases, and minimal residual diseasesACTIVE—
009Downloadable educational materials, namely, video recordings, books, and printable booklets on therapeutic polypeptides and use thereofACTIVE—
042Providing medical and scientific research information regarding therapeutic polypeptides and use thereof; providing a website featuring medical and scientific research information regarding antibody derivatives and use thereof; providing scientific information regarding antibody derivatives and use thereofACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 27, 2026DOCKASSIGNED TO EXAMINER—
Oct 26, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 15, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 15, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance